Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. - Wikidata - awgldk - TriplyDB

Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.

Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.

http://www.wikidata.org/entity/Q50710550

about

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis First isolations of Segniliparus rugosus from patients with cystic fibrosis MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections.Intra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from patients with cystic fibrosis Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.Clinical significance of microbial infection and adaptation in cystic fibrosis.Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis.Proposed definitions for epidemiologic and clinical studies of Mycobacterium avium complex pulmonary disease.Mycobacterium abscessus morphotype comparison in a murine model.Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.Mycobacterium chimaera pulmonary infection complicating cystic fibrosis: a case report.Infection control in cystic fibrosis.Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2003.Tuberculosis, lung infections, interstitial lung disease, social issues and journalology in AJRCCM 2003.Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease Is limited computed tomography the future for imaging the lungs of children with cystic fibrosis?Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group.Antiinflammatory therapies for cystic fibrosis: past, present, and future.Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.Evaluation and management of patients with pulmonary nontuberculous mycobacterial infections.Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City.Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel.Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.Update on antibiotics for infection control in cystic fibrosis.Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis Lung transplantation: infection, inflammation, and the microbiome.Current dilemmas in antimicrobial therapy in cystic fibrosis.Inhaled liposomal amikacin.Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008-2013.Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.Vaccine strategies against cystic fibrosis pathogens.Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis.

P2860

Q26775974-4FDDA27C-900F-4847-B32D-54D44A8DA20A Q31120557-2F37FA71-4BEC-467C-A8C7-A8B056BC611B Q33578979-C62A23AF-F38E-40F9-9D4E-D02E7430E980 Q33885049-B4EB3053-228E-4122-8D88-890E36187A50 Q34425805-94DCE56A-AB88-43A6-A398-63274557964B Q34491552-7F14DEE9-58CD-4792-98D2-1E5B4DCD4107 Q34603485-6791609B-BA35-4CD3-B247-2816937AD8FE Q34610992-1F3E63CB-3898-42E8-95CC-24C2D4138A4B Q35005445-840F8BDC-D84C-44C8-A880-117C2C77D6AA Q35050258-D6B817D0-8050-4ACB-AE65-4B1BD7678526 Q35078472-C600AA12-14B6-4284-B423-907D8BCF5230 Q35094033-FF834AE5-5EF0-4455-9CF7-97EE70026785 Q35213050-87D4D827-80CA-41B0-8F17-0098B161608D Q35298968-E40826D0-A4BF-4BFF-8500-2C9A19FDC2BB Q35545544-DABF666D-4786-4BA0-81F9-554417794443 Q35626617-B87D0859-9FC6-498A-8956-A065822D8F17 Q35626620-98D224C7-B2B7-4B63-ABE4-1BFF6722B2DE Q36128623-EB92979B-B217-4C8F-9580-ABA19A9D82E4 Q36152917-9084DCCB-89A8-4BB7-A38B-53FE93A9679B Q36156072-09B9CC37-7214-4DF9-A7D6-FC9E7B1CA958 Q36174064-919C9E87-E866-4D76-B818-56A998CFEEC2 Q36174470-A8FF7DA9-6BEA-4059-A74D-A16941DBAD08 Q36658777-512E30DE-21FB-4666-B038-C7FBDCBFF8FB Q36670892-686F0B60-7F2E-4A05-B3E9-190EF57911D4 Q36688950-F9C386C2-F57D-4FBF-9F47-EBD82750DECC Q36944698-478AC1A8-5A73-4EFC-8996-E06C85D94692 Q36944748-5FFA7606-644A-431F-8E25-6A9448CB0719 Q36968540-1EC2B3B9-8353-4738-BD88-2F87BACE1116 Q37334924-7F1AB91B-3141-4FDD-B929-7A384C0D72D5 Q37608274-D4637E11-7DB0-4D50-ABA1-B1D630F34EE8 Q37679780-79CA1B9F-4DC7-454F-9D55-843678C32D4E Q37832677-C71C600B-3F77-49F3-90E7-CB065EF0745E Q38042719-30046463-2334-4C1B-B91E-388C9E4B2150 Q38216555-DC98D876-E8AC-43CE-AE8C-DA72ED69683B Q38749090-048F1B41-0BDD-4F4A-990A-B11196A62977 Q38764394-666D44CE-DEF6-4FC4-A740-A201A0EECD4E Q39343316-E7FCC7FF-7FF5-4F5F-BFF3-B49791B5B38E Q40252432-F291BA0A-C7E3-43D9-8C6E-9FD6BE8FB1AE Q40262035-C8D27A52-4F6C-45AA-987C-ED72E773DD70 Q41866799-F87858B5-475F-4BD8-A694-CC56869A9E3E

P2860

Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.

http://www.wikidata.org/entity/Q50710550

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.

@en

Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.

@nl

type

label

Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.

@en

Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.

@nl

prefLabel

Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.

@en

Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.

@nl

P1433

Q50710550-28B21B85-726B-4A5F-BE08-C657CFE36335

P1476

Q50710550-A2952FC9-9FCF-4092-BD1B-AA5EF66392CE

P2093

Q50710550-0E72D65E-7D8C-40DF-A48B-530C1A15E006

Q50710550-1ED8C758-3EE3-4486-8DCF-46617FB836ED

Q50710550-29F313FD-DE00-4064-92B2-0DA08E1E8412

Q50710550-3BCDA665-F1DE-4480-B484-64C997D67B5D

Q50710550-57BEEFCB-58F9-4FBD-9EA5-9B5259B9031C

Q50710550-65F8FB07-B4A2-434E-B47B-607CB8F67533

Q50710550-897F895E-7689-49D2-B5D8-473FA40A8EB4

Q50710550-E6B40866-7D87-48D2-8438-7953ECF96D9D

Q50710550-F6B03C48-C1D7-48DB-A6A8-4B1E9EC4EF51

P2860

Q50710550-15F42902-C40C-40B9-8DF4-B7712B5E1F0E

Q50710550-169E573A-474E-469E-AACD-0D61B3403DC7

Q50710550-642CFF5F-CF2C-4988-BB3A-2CF5586E5F92

Q50710550-9C9FD3DA-E1EA-4808-83D5-812C9EADB15A

Q50710550-BDB83584-BC18-4DB2-B473-8873F2852319

Q50710550-C6312748-20BB-459A-B12C-63FADEFE42E1

Q50710550-D2402E47-3EA3-49B6-BAF4-E413A4CE1539

Q50710550-E749D74C-F7DC-4083-ABDA-A5CAF5B4F159

Q50710550-EB86F104-F842-40B2-BFD7-E0060C499223

P304

Q50710550-B3268ED6-5BFB-48DB-ABFF-8EF1592697A4

P31

Q50710550-0B550FAE-1A35-407F-B664-BECE1BAD629A

P356

Q50710550-BB549A50-122A-4B17-8535-E9540BE3E567

P407

Q50710550-5ED061CA-978B-4C6D-8BF5-2C8570780EF4

P433

Q50710550-B616AD02-F877-4D7B-9DCD-8A76EEA11D23

P478

Q50710550-0003985A-7098-4DA9-9D67-1832E6A0D9B6

P577

Q50710550-8A86AB7D-11A8-4409-9489-0B2C4DF6ED6F

P698

Q50710550-DD9A23D2-2768-4E06-B31E-7E8127DB33F0

P921

Q50710550-5B6339D1-1639-42CF-A6A7-C09279DB6DC4

P356

RCCM.200207-679OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.

@en

P2093

Allison Handler

http://www.w3.org/2001/XMLSchema#string

David J Weber

http://www.w3.org/2001/XMLSchema#string

Gail Tudor

http://www.w3.org/2001/XMLSchema#string

Ji-Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Joseph Tomashefski

http://www.w3.org/2001/XMLSchema#string

Kenneth N Olivier

http://www.w3.org/2001/XMLSchema#string

Michael R Knowles

http://www.w3.org/2001/XMLSchema#string

Nontuberculous Mycobacteria in Cystic Fibrosis Study Group

http://www.w3.org/2001/XMLSchema#string

Paul L Molina

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of Spirometry, 1994 Update. American Thoracic Society

Mycobacterial isolations in young adults with cystic fibrosis.

Prospective study of mycobacterial infections in patients with cystic fibrosis.

Nontuberculous mycobacteria in adult patients with cystic fibrosis.

Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease.

Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic.

Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

Ventilatory functions of normal children and young adults--Mexican-American, white, and black. I. Spirometry.

Fatal pulmonary infection with Mycobacterium fortuitum in cystic fibrosis.

P304

835-840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200207-679OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12433669

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis